We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+3.3%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$254B
AUM Growth
+$10.5B
Cap. Flow
+$4.16B
Cap. Flow %
1.64%
Top 10 Hldgs %
15.87%
Holding
4,218
New
135
Increased
2,755
Reduced
887
Closed
134

Top Buys

Rank Stock Value
1
DXC icon
DXC Technology
DXC
+$213M
2
MO icon
Altria Group
MO
+$206M
3
XOM icon
ExxonMobil
XOM
+$105M
4
MSFT icon
Microsoft
MSFT
+$86.8M
5
META icon
Meta Platforms (Facebook)
META
+$75.5M

Sector Composition

Rank Sector Weight
1 Financials 15.9%
2 Technology 15.77%
3 Healthcare 13.92%
4 Industrials 10.5%
5 Consumer Discretionary 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRSO icon
3926
Peraso
PRSO
$10.8M
$41K ﹤0.01%
30
-2
-6% -$2.09K
TGA
3927
DELISTED
Transglobe Energy Corp
TGA
$41K ﹤0.01%
31,199
-7,619
-20% -$11.1K
SRRA
3928
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$41K ﹤0.01%
884
-87
-9% -$4.44K
SPHS
3929
DELISTED
Sophiris Bio, Inc.
SPHS
$41K ﹤0.01%
19,042
+3,815
+25% +$9.34K
CASI
3930
DELISTED
CASI Pharmaceuticals
CASI
$40K ﹤0.01%
3,832
-38
-1% -$404
ANIX icon
3931
Anixa Biosciences
ANIX
$115M
$39K ﹤0.01%
34,351
CYRN
3932
DELISTED
CYREN Ltd.
CYRN
$39K ﹤0.01%
966
AFMD
3933
DELISTED
Affimed
AFMD
$38K ﹤0.01%
1,876
-468
-20% -$10.4K
RHE
3934
DELISTED
Regional Health Properties, Inc.
RHE
$38K ﹤0.01%
3,380
ARLZ
3935
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$38K ﹤0.01%
28,175
-7,640
-21% -$11K
DARE icon
3936
Dare Bioscience
DARE
$19.9M
$37K ﹤0.01%
712
-34
-5% -$1.98K
FALC
3937
DELISTED
FalconStor Software Inc
FALC
$37K ﹤0.01%
143,545
-7,437
-5% -$2.26K
HPJ
3938
DELISTED
Highpower International Inc
HPJ
$37K ﹤0.01%
10,264
-1,369
-12% -$6.41K
AIM
3939
AIM ImmunoTech
AIM
$7.6M
$37K ﹤0.01%
17
RFIL icon
3940
RF Industries
RFIL
$142M
$36K ﹤0.01%
19,760
BYU
3941
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
$35K ﹤0.01%
+9
New +$25.8K
FOCL
3942
EDAP TMS S.A.
FOCL
$233M
$34K ﹤0.01%
10,586
-3,497
-25% -$9.95K
OGEN icon
3943
Oragenics
OGEN
$2.47M
$33K ﹤0.01%
5
VKTX icon
3944
Viking Therapeutics
VKTX
$3.87B
$33K ﹤0.01%
31,264
NEPT
3945
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$33K ﹤0.01%
29
-11
-28% -$15.3K
DDE
3946
DELISTED
Dover Downs Gaming & Entertain
DDE
$33K ﹤0.01%
30,139
XPLR
3947
DELISTED
Xplore Technologies Corp.
XPLR
$33K ﹤0.01%
16,945
LENS
3948
DELISTED
Presbia PLC Ordinary Shares
LENS
$33K ﹤0.01%
14,898
-1
-0% -$3
ROKA
3949
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$32K ﹤0.01%
12,233
FAC
3950
DELISTED
First Acceptance Corp.
FAC
$32K ﹤0.01%
28,734

Similar funds

Geode Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Geode Capital Management held 4,218 positions worth $254B, up 4.3% from $244B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Geode Capital Management's Q2 2017 filing shows 135 new, 2,755 increased, 887 reduced and 134 closed positions. Its largest new stake was DXC Technology: 3,214,073 shares worth $213M. The largest sale was Yahoo Inc, an estimated $403M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Geode Capital Management's largest Q2 2017 buy was DXC Technology: 3,214,073 shares worth $213M.
  • Geode Capital Management added most to Altria Group in Q2 2017, an estimated $206M increase.
  • Geode Capital Management's biggest Q2 2017 reduction was Home Depot, cutting an estimated $164M.
  • Geode Capital Management fully exited Yahoo Inc in Q2 2017, selling an estimated $403M.
  • Geode Capital Management's ten largest holdings make up 16% of its $254B portfolio in Q2 2017.
  • Geode Capital Management opened 135 new positions and closed 134 in Q2 2017.
  • Geode Capital Management's portfolio value rose 4.3% quarter-over-quarter to $254B.

Based on Geode Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.